PDB51 COST-EFFECTIVENESS OF EXENATIDE VERSUS INSULIN GLARGINE AND VERSUS BIPHASIC INSULIN ASPART FOR THE TREATMENT OF TYPE 2 DIABETES IN PORTUGAL- A LONG-TERM HEALTH ECONOMIC ANALYSIS
Nov 1, 2010, 00:00
10.1016/S1098-3015(11)72109-X
https://www.valueinhealthjournal.com/article/S1098-3015(11)72109-X/fulltext
Title :
PDB51 COST-EFFECTIVENESS OF EXENATIDE VERSUS INSULIN GLARGINE AND VERSUS BIPHASIC INSULIN ASPART FOR THE TREATMENT OF TYPE 2 DIABETES IN PORTUGAL- A LONG-TERM HEALTH ECONOMIC ANALYSIS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)72109-X&doi=10.1016/S1098-3015(11)72109-X
First page :
A293
Section Title :
RESEARCH POSTER ABSTRACTS
Open access? :
No
Section Order :
268